Help us crack prostate cancer

Sledgehammer Fund

Our Sledgehammer Fund aims to wake up the nation to a disease that kills 10,000 men every year. That's one man every hour, and the number of men with the disease is rising at an alarming rate.

While it is already the most common cancer in men, prostate cancer is predicted to become the most common cancer of all in the UK by 2030. It's as big an issue for men as breast cancer is for women - yet prostate cancer gets just a fraction of the money for research. The disease is poorly understood, the tests aren't good enough, and the treatments can have life-changing side effects.

Men deserve better.

Join the fight and help us crack prostate cancer:

Donate Now Become A Campaigner

Become A Volunteer Do A Fundraising Event

You can find out more about prostate cancer across our website.

Questions about our campaign? Read our FAQ or tell us what you think at

Today (Friday 15 August 2014) the National Institute for Health and Care Excellence (NICE) confirmed its refusal to let men with advanced prostate cancer have abiraterone, which could extend life and delay their need for chemotherapy with its devastating side effects. Prostate Cancer UK is urging NICE and the manufacturer to work together and do whatever is necessary to make the drug available without further delay.

Read more

See all Health policy and campaigns